Acurx Pharmaceuticals, Inc.

ACXP ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Jan 8, 2025 OWNERSHIP DOCUMENT
4 Jan 8, 2025 OWNERSHIP DOCUMENT
424B5 Jan 7, 2025 424B5
8-K Jan 7, 2025 FORM 8-K
424B3 Jan 6, 2025 424B3
8-K Nov 13, 2024 FORM 8-K
10-Q Nov 12, 2024 10-Q
8-K Aug 9, 2024 FORM 8-K
10-Q Aug 8, 2024 10-Q
4 Jun 18, 2024 OWNERSHIP DOCUMENT
4 Jun 18, 2024 OWNERSHIP DOCUMENT
4 Jun 18, 2024 OWNERSHIP DOCUMENT
4 Jun 18, 2024 OWNERSHIP DOCUMENT
4 Jun 18, 2024 OWNERSHIP DOCUMENT
8-K Jun 17, 2024 FORM 8-K
8-K May 15, 2024 FORM 8-K
10-Q May 14, 2024 10-Q
ARS Apr 29, 2024 ARS
DEFA14A Apr 29, 2024 DEFA14A
DEF 14A Apr 29, 2024 DEF 14A
RW Apr 17, 2024 RW
4 Apr 3, 2024 OWNERSHIP DOCUMENT
4 Apr 3, 2024 OWNERSHIP DOCUMENT
4 Apr 3, 2024 OWNERSHIP DOCUMENT
FWP Apr 2, 2024 FWP
← Newer Page 5 of 10 · 243 filings Older →